(+-)-(1S*,2S*,4S*,6R*,8R*,9R*)-1,9,10,11-TETRACHLOR-6-ISOPROPYL-12,12-DIMETHOXY-2-METHYL-5-OXATRICYCLO-[7.2.1.0(2,8).0(4,6)]-DODEC-10-EN-3,7-DIONE
Compound with spectra: 1 NMR
![(+-)-(1S*,2S*,4S*,6R*,8R*,9R*)-1,9,10,11-TETRACHLOR-6-ISOPROPYL-12,12-DIMETHOXY-2-METHYL-5-OXATRICYCLO-[7.2.1.0(2,8).0(4,6)]-DODEC-10-EN-3,7-DIONE](/api/compound/7fWrh8UPMZ3.png?ph=true&h=300&w=458 "(+-)-(1S*,2S*,4S*,6R*,8R*,9R*)-1,9,10,11-TETRACHLOR-6-ISOPROPYL-12,12-DIMETHOXY-2-METHYL-5-OXATRICYCLO-[7.2.1.0(2,8).0(4,6)]-DODEC-10-EN-3,7-DIONE")
| SpectraBase Compound ID | 7fWrh8UPMZ3 |
|---|---|
| InChI | InChI=1S/C17H18Cl4O5/c1-6(2)14-10(22)7-13(3,11(23)12(14)26-14)16(21)9(19)8(18)15(7,20)17(16,24-4)25-5/h6-7,12H,1-5H3/t7-,12+,13-,14-,15-,16+/m1/s1 |
| InChIKey | VAWJZBPTRSYTMY-WZRGNRLHSA-N |
| Mol Weight | 444.1 g/mol |
| Molecular Formula | C17H18Cl4O5 |
| Exact Mass | 441.990834 g/mol |
| Enantiomer InChIKey | VAWJZBPTRSYTMY-BAZODCAZSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
6H,13H-5,13:6,12-Dietheno-5a,12a-(methaniminomethano)-1H,5H,8H,12H-[1,2,4]triazolo[1,2-a][1,2,4]triazolo[1',2':1,2]pyridazino[4,5-d]pyridazine-18-acetic acid, 2,3,9,10-tetrahydro-.alpha.-(2-methylpropyl)-1,3,8,10,17,19-hexaoxo-2,9-diphenyl-, hexyl ester, stereoisomer
4H-9,12:15,18-Dietheno-28,31-imino-26,23-methenopyrrolo[2,3-n][1,19,6]dioxaazacyclohentriacontine-6,21,24(5H,22H,25H)-trione, 30-ethyl-2-[(3-ethyl-1,5-dihydro-4-methyl-5-oxo-2H-pyrrol-2-ylidene)methyl]-8,13,14,19-tetrahydro-3,29,34-trimethyl-, (Z,Z,Z)-
Methyl 2.beta.-(2'-(m-isopropyl-phenyl)ethyl)-1.beta.,3.alpha.-dimethyl-cyclohexanecarboxylate (so name and structure in Anderson & Botto) but MS (intense fragement at m/z = 187) and RT suggest 2.alpha.-epimer instead, with Reg. No. 19556-80-0? a methyl seco-dehydro-abietate
1-(1.lambda.6,2lambd6,3lambd6,4lambd6,5lambd6,6lambd6,7lambd6,8lambd6,9lambd6,10lambd6,11lambd6,12lambd6-dodecaboranonadecacyclo[5.5.0.01,3.01,4.02,10.02,11.02,12.03,5.03,10.04,6.04,7.05,9.05,10.06,8.06,9.07,12.08,11.08,12.09,11]dodecan-1-yl)-3-phenyl-prop-2-en-1-ol
2-Propenoic acid, 3-phenyl-, 1,1a,1b,1c,2a,3,3a,4,6a,6b,7,8-dodecahydro-3a,6b-dihydroxy-1,1,5,7-tetramethyl-4-oxo-2a-[[(1-oxo-3-phenyl-2-propenyl)oxy]methyl]-8aH-cyclopropa[5',6']benz[1',2':7,8]az uleno[5,6-b]oxirene-8,8a-diyl ester, [1aR-(1a.alpha.,1b.beta.,1c.beta.,2a.beta.,3a.beta.,6a.alpha.,6b.alpha.,7.alpha.,8.beta.,8a.alpha.)]-
Cobalt, bis(cyano-C)(8,11-diethyl-2,3,3a,7,8,9,10,11,12,16,17,20a-dodecahydro-3a,5,8,9,12,14,17,17-octamethyl-7,12,16,20a-tetrapropyl-10,13-imino-4,20:9,16:18,15-trinitrilo-6H-cyclononadeca[b]furanato-N21,N22,N23,N24)-, stereoisomer
Water-dilutable, short-oil alkyd based on dehydrated castor oil (34% triglycerides, 25% phthalic anhydride); 55% solution in an aqueous glycol ether-alcohol mixture, neutralized with dimethylethanolamine
13',16':18',21'-dietheno-1,1''-diethyl-3',14',20',31'-tetramethyldispiro[piperidine-4,17'-[5,12,22,29]tetraoxa[37,40,41]triazatetracyclo[31.13.1.0.(4,45).0(30,35)]heptatetraconta-1',3',13',15',18',20',30',34',35',45'-decaene-47',4''-piperidine]-38',42'-dione
Cobalt, bis(cyano-C)(8,11-diethyl-2,3,3a,7,8,9,10,11,12,16,17,20a-dodecahydro-3a,4,8,9,12,14,17,17-octamethyl-7,12,16,20a-tetrapropyl-10,13-imino-4,20:9,16:18,15-trinitrilo-6H-cyclononadeca[b]furan-5(4H)-onato-N21,N22,N23,N24)-, stereoisomer
{(4a,5,6,7,7a-.eta.)-4-(2",2"-Dimethyl-1",3"-dioxolan-4"-yl)-3a,5,8,8a-tetrahydro-2,2-dimethyl-4H-indeno[5,6-d]-1,3-dioxol-5-yl}-{(4',5',6',7',7a'-.eta.)-5'-(chloromercurio)-4'-(2"',2"'-dimethyl-1'",3'"-dioxolan-4"'-yl}-3a',5',8',8a'-tetrahydro-2',2'-dimethyl-4H-indeno5,6-d]-1',3'-dioxol-5'-yl}- iron (II)
| Title | Journal or Book | Year |
|---|---|---|
| Versuche zur enantiomerenreinen Synthese des Chatancins, 1. Mitt. Synthese von (1R,2S,6S,7R,8S,3?S)-2-(4?-Benzyloxy-3?-methylbutoyl)-7-hydroxy-8-isopropyl-1-methylbicyclo [4.4.0]decan-4-on | Monatshefte f�r Chemie Chemical Monthly | 1994 |